Invasive bladder cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/20/suppl_4/iv79/345824/mdp136.pdf
Reference23 articles.
1. The World Health Organization International Society of Urologic Pathology (ISUP) consensus classification of urothelial (transitional cell) lesions, neoplasms of the urinary bladder. Bladder Consensus Conference Committee;Epstein;Am J Surg Pathol,1998
2. Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1, and TIS);Smith;J Urol,1999
3. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a metaanalysis of published results of randomized clinical trials;Sylvester;J Urol,2004
4. Twenty-five-year experience in the management of invasive bladder cancer by radical cystectomy;Skinner;Eur Urol,1998
5. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients;Stien;J Clin Oncol,2001
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Review of Progress in the Construction and Application of Human-Derived Xenograft Models for Bladder Cancer;Journal of Biosciences and Medicines;2022
2. Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2–4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials;European Urology Oncology;2019-05
3. Relationship between the genetic expression of WTAP and bladder cancer and patient prognosis;Oncology Letters;2018-10-05
4. Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?;Urologic Oncology: Seminars and Original Investigations;2018-03
5. Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers;Bladder Cancer;2018-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3